Glucose-6-phosphate isomerase is associated with disease activity and declines in response to infliximab treatment in rheumatoid arthritis

BACKGROUND: Rheumatoid arthritis (RA), a systemic autoimmune disease characterized by synovial inflammation, can cause cartilage and bone damage as well as disability. The aim of this study was to explore whether serum glucose-6-phosphate isomerase (GPI) is correlated with disease activity and the v...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jing, Zhang, Xiao-Ying, Li, Ru, Liu, Jing, Ye, Hua, Zhang, Xue-Wu, Li, Zhan-Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176457/
https://www.ncbi.nlm.nih.gov/pubmed/32187052
http://dx.doi.org/10.1097/CM9.0000000000000750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176457/
https://www.ncbi.nlm.nih.gov/pubmed/32187052
http://dx.doi.org/10.1097/CM9.0000000000000750

Ejemplares similares